SCOPUS 정보 검색 플랫폼

Journal of Cancer Research and Clinical Oncology

Volumn 120, Issue 12, 1994, Pages 754-757

Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer

(6) Bokemeyer, C a Schmoll, H J a Natt, F b Knoche, M a Beyer, J c Souchon, R d

a HANNOVER MEDICAL SCHOOL (Germany)

b Chirurgische Abteilung (Germany)

c FREIE UNIVERSITÄT BERLIN (Germany)

d Kinderneurologisches Zentrum SPZ (Germany)

Author keywords

Chemotherapy; Cisplatin resistance; Paclitaxel; Testicular cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESISTANCE; HUMAN; MALE; MUCOSA INFLAMMATION; NEUROTOXICITY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TESTIS CANCER;

ADULT; CISPLATIN; DNA DAMAGE; DRUG RESISTANCE; GERMINOMA; HUMAN; MALE; PACLITAXEL; TESTICULAR NEOPLASMS;

EID: 0028033791 PISSN: 01715216 EISSN: 14321335 Source Type: Journal
DOI: 10.1007/BF01194278 Document Type: Article

Times cited : (32)

References (15)

1
- 0027288855
- Treatment of relapsed germ cell tumours with vinorelbine: a trial of the phase I/II-study group of the Association for Medical Oncology of the German cancer society
- (1993) Onkologie , vol.16 , pp. 29-31
- Bokemeyer, C.¹ Droz, J.P.² Hanauske, A.³ Schröder, M.⁴ Queißer, W.⁵ Schmoll, H.J.⁶

2
- 0025809298
- A phase I trial of taxol given by a 6-hour intravenous infusion
- (1991) J Clin Oncol , vol.9 , pp. 1261-1267
- Brown, T.¹ Havlin, K.² Weiss, G.³ Cagnola, J.⁴ Koeller, J.⁵ Kuhn, J.⁶ Rizzo, J.⁷ Craig, J.⁸ Phillips, J.⁹ van Hoff, D.¹⁰

3
- 0026023964
- Enhanced host cell reactivation of demaged plasmid DNA in HeLa cells resistant to cisdiamminedichloroplatinum (II)
- (1991) Cancer Res , vol.51 , pp. 601-605
- Chao, C.C.K.¹ Lee, Y.L.² Cheng, P.W.³ Lin-Chao, S.⁴

4
- 0025152039
- Treatment of testicular cancer: a new and improved model
- (1990) J Clin Oncol , vol.8 , pp. 1777-1781
- Einhorn, L.H.¹

5
- 0027717905
- New cytostatic drugs in ovarian cancer
- (1993) Annals of Oncology , vol.4 , pp. 63-70
- Hansen, H.H.¹ Eisenhauer, E.A.² Hansen, M.³ Neijt, J.P.⁴ Piccart, M.J.⁵ Sessa, C.⁶ Thigpen, J.T.⁷

6
- 0025035342
- Highdose epidoxorubicin in refractory or relapsed nonseminomatous testicular cancer: a phase II study
- (1990) Ann Oncol , vol.1 , pp. 375-376
- Harstrick, A.¹ Schmoll, H.J.² Wilke, H.³ Schöber, C.⁴ Stahl, M.⁵ Köhne-Wömpner, C.⁶ Bokemeyer, C.⁷ Dölken, G.⁸ Burk, K.⁹ Poliwoda, H.¹⁰

7
- 13344282373
- Deficient removal of the major platinum-DNA intrastrand crosslinks in the sequences pGpG and pApG appears characteristic of testicular teratoma cell lines derived from tumours from untreated patients and may account for their sensitivity to cisplatin
- (1992) Proc Am Soc. Oncol , vol.11 , pp. 100
- Hill, B.T.¹ Shellard, S.A.² Whelan, R.D.H.³ Pera, M.F.⁴ Harstrick, A.⁵ Fichtinger-Schepman, A.M.J.⁶

8
- 0013692834
- Phase II trial of taxol in cisplatin-resistant germ cell tumour (GCT) patients (PTS)
- (1994) Proc Am Soc Clin Oncol , vol.13 , pp. 232
- Hutter, H.¹ Motzer, R.² Schwartz, L.³ Fischer, P.⁴ Bajorin, D.⁵ Scher, H.⁶ Bosl, G.⁷

9
- 0028078681
- Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian, cancer
- (1994) J Natl Cancer Inst , vol.86 , pp. 18-24
- Kohn, E.C.¹ Sarosy, G.² Bicher, A.³ Link, C.⁴ Christian, M.⁵ Steinberg, S.M.⁶ Rothenberg, M.⁷ Adamo, D.O.⁸ Davis, P.⁹ Ognibene, F.P.¹⁰ Cunnion, R.E.¹¹ Reed, E.¹²

10
- 0022575675
- Phase I trial of taxol given as a 3-hour infusion every 21 days
- (1986) Cancer Treat Rep , vol.70 , pp. 605-607
- Kris, M.G.¹ O'Connel, J.P.² Gralla, R.J.³ Wertheim⁴ Parente, R.M.⁵ Schiff, P.B.⁶ Young, C.W.⁷

11
- 0024327106
- Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms
- (1989) Ann Intern Med , vol.111 , pp. 273-279
- McGuire, W.P.¹ Rowinsky, E.K.² Rosenshein, N.B.³ Grumbine, F.C.⁴ Ettinger, D.S.⁵ Artrong, D.U.⁶ Donehower, R.C.⁷

12
- 84936396058
- Reed E, Parker RJ, Dabholkar M (1992) Taxol effect on cisplatin-DNA adduct repair in human ovarian cancer cells (abstract). Second National Cancer Institute Workshop on Taxol, Alexandria, Va.

13
- 0025333168
- Taxol: a novel investigational antimicrotubule agent
- (1990) J Natl Cancer Inst , vol.82 , pp. 1247-1259
- Rowinsky, E.K.¹ Cazenave, L.A.² Donehower, R.C.³

14
- 0013333101
- Promotion of microtubule assembly in vitro by taxol
- (1979) Nature , vol.277 , pp. 655-667
- Schiff, P.B.¹ Fant, J.² Horwitz, S.B.³

15
- 0001104385
- Taxol in relapsed ovarian cancer: high vs low dose and short vs long infusion
- (1993) Proc. Am Soc Clin Oncol , vol.12 , pp. 256
- Swenerton, K.¹ Eisenhauer, E.² ten Bokkel Huinink, W.³ Myles, J.⁴ Mangini, C.⁵ van der Burg, M.⁶ Kerr, I.⁷ Gianni, L.⁸ Vermoken, J.⁹ Buser, K.¹⁰ Sadura, A.¹¹ Bacon, M.¹² Santabarbara, P.¹³ Onetto, N.¹⁴ Canetta, J.¹⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.